INTERNATIONAL PATENT: NEWAMSTERDAM PHARMA B.V., DAVIDSON, MICHAEL, HARVEY FILES APPLICATION FOR "FIXED DOSE COMBINATION COMPOSITION OF OBICETRAPIB AND EZETIMIBE"

GENEVA, July 14 -- NEWAMSTERDAM PHARMA B.V. (Gooimeer 2-351411 DC Naarden), DAVIDSON, Michael, Harvey (c/o NewAmsterdam Pharma B.V.Gooimeer 2-351411 DC Naarden) filed a patent application (PCT/US2024/010145) for "FIXED DOSE COMBINATION COMPOSITION OF OBICETRAPIB AND EZETIMIBE" on Jan 03, 2024. With publication no. WO/2025/147235, the details related to the patent application was published on Jul 10, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KASTELEIN, Johannes, Jacob Pieter (c/o NewAmsterdam Pharma B.V.Gooimeer 2-351411 DC Naarden), DITMARSCH, Marc (c/o NewAmsterdam Pharma B.V.Gooimeer...